PORT ORCHARD — On Monday, Ione George, lead prosecutor in the case against David Kalac, addressed the Kitsap County Superior Court jury using the words Kalac wrote in an internet posting describing ...

After missing three games and a bye wek due to a knee injury, the Raiders' second-year tight end showed exactly why he was the first one off the board at the position in fantasy drafts this year by ...

The Seahawks worked out a free agent tight end amid significant injuries. The TE, a former FCS All-American, has bounced between several NFL practice squads since 2023. If signed, the TE would provide ...

The Seahawks waived safety Jerrick Reed II to make room on the roster for trade acquisition receiver Rashid Shaheed, and also made an addition to the practice squad. The Seahawks added a speedy ...

Week 10 is here in the fantasy football world, and as such, the fantasy football rankings are once again jumbled up. Some players who were nearly on top of the mountain have slipped back into the ...

Hamilton man Joseph Te Huia was acting in a 'delusional' manner after breaking into a woman's home and brutally attacking her. Photo / 123rf A woman subjected to a horrific attack after a man broke ...

Although Houston Cougars football is coming off a very disappointing loss to West Virginia, UH is still 7-2 and well ahead of schedule in what has been a major turnaround season. While the Cougars ...

Te Pāti Māori’s leadership is willing to meet with estranged MPs Mariameno Kapa-Kingi and Tākuta Ferris, the National Iwi Chairs Forum says. Ngāti Kahungunu chairman Bayden Barber sat down with the ...

Suffice to say, the Denver Broncos' marquee addition of tight end Evan Engram hasn't gone entirely to plan. Engram, a former Pro Bowler, was signed to be the feared "Joker" in head coach Sean Payton's ...

Taysom Hill is always going to be tantalizing in fantasy football. This is a guy who qualifies at tight end yet also runs the ball and throws the ball. But the way the New Orleans Saints are using him ...

A new drug combo of enzalutamide and hormone therapy has been shown to extend survival for men with recurring prostate cancer, reducing death risk by over 40%. The study followed more than 1,000 ...